Literature DB >> 17189583

Hospitals' compliance with prophylaxis guidelines for venous thromboembolism.

Hsing-Ting Yu1, Michelle L Dylan, Jay Lin, Robert W Dubois.   

Abstract

PURPOSE: A study was conducted to evaluate compliance with the Sixth American College of Chest Physicians (ACCP) Consensus Conference on Antithrombotic Therapy guidelines for the prevention of venous thromboembolism (VTE) in hospitals.
METHODS: Using the HealthFacts database, hospitalized patients, age 40 years or more, with medical conditions at risk for VTE (surgical, trauma, and acute spinal injury patients) were identified. Hospital admissions on or after January 1, 2001, and concluded by March 31, 2005, were included if they met any of the following conditions as defined in the ACCP Consensus Conference on Antithrombotic Therapy guidelines: patients at risk of VTE medical conditions, major orthopedic surgery, general surgery, gynecological surgery, urologic surgery, trauma, neurosurgery, and acute spinal cord injury. Hospitalizations were identified using the International Classification of Diseases, 9th Revision, Clinical Modification codes. The primary objective was to examine whether patients received one of the indicated anticoagulants at the proper dosage and during the relevant hospital days as determined in the ACCP guidelines. Rates of compliance were assessed, and the reasons for guideline noncompliance were also determined.
RESULTS: The overall compliance rate with ACCP guidelines was 13.3% (ranging from 2.8% for neurosurgery to 52.4% for orthopedic surgery) in the 123,304 hospital admissions that were reviewed. Only 15.3% of patients with at-risk medical conditions received prophylaxis in accordance with ACCP guidelines. Potential reasons for guideline noncompliance among selected conditions included the omission of prophylaxis, inadequate prophylaxis duration, and the wrong type of anticoagulant.
CONCLUSION: A retrospective study found low rates of compliance with guidelines for thromboprophylaxis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17189583     DOI: 10.2146/ajhp060115

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  25 in total

1.  Retrospective analysis of adherence to thromboprophylaxis after orthopedic surgery in a community hospital.

Authors:  Megan A McElwee; Aaron Tejani; Lily Cheng
Journal:  Can J Hosp Pharm       Date:  2010-03

2.  Variation in physician deep vein thrombosis prophylaxis attitudes and practices at an academic tertiary care center.

Authors:  Erin M Galbraith; Bonnie M Vautaw; Mary Grzybowski; Peter K Henke; Tomas W Wakefield; James B Froehlich
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300

3.  Venous thromboembolic disease in colorectal patients.

Authors:  Michael P McNally; Christopher J Burns
Journal:  Clin Colon Rectal Surg       Date:  2009-02

Review 4.  Standard or extended-duration prophylaxis in medical patients? A review of the evidence.

Authors:  J E Stark; W J Smith
Journal:  J Thromb Thrombolysis       Date:  2011-10       Impact factor: 2.300

5.  Review of thromboembolic prophylaxis in patients attending Cork University Hospital.

Authors:  Stephen Byrne; Daniel Timothy Weaver
Journal:  Int J Clin Pharm       Date:  2013-03-15

6.  Venous thromboembolic events in hospitalised medical patients.

Authors:  Gregory Piazza; John Fanikos; Maksim Zayaruzny; Samuel Z Goldhaber
Journal:  Thromb Haemost       Date:  2009-09       Impact factor: 5.249

7.  Adding chemoprophylaxis to sequential compression might not reduce risk of venous thromboembolism in bariatric surgery patients.

Authors:  Michel Gagner; Faith Selzer; Steve H Belle; Marc Bessler; Anita P Courcoulas; Gregory F Dakin; Dan Davis; William B Inabnet; James E Mitchell; Alfons Pomp; Gladys W Strain; Walter J Pories; Bruce M Wolfe
Journal:  Surg Obes Relat Dis       Date:  2012-07-31       Impact factor: 4.734

8.  Improved venous thromboembolism prophylaxis by pharmacist-driven interventions in acutely ill medical patients in Belgium.

Authors:  Audrey Vervacke; Sophie Lorent; Serge Motte
Journal:  Int J Clin Pharm       Date:  2014-08-03

Review 9.  Contemporary issues in the prevention and management of postthrombotic syndrome.

Authors:  Sara R Vazquez; Andrew Freeman; Ryan C VanWoerkom; Matthew T Rondina
Journal:  Ann Pharmacother       Date:  2009-09-08       Impact factor: 3.154

10.  Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start).

Authors:  A Amin; A C Spyropoulos; P Dobesh; A Shorr; M Hussein; E Mozaffari; J S Benner
Journal:  J Thromb Thrombolysis       Date:  2010-04       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.